Tibet Pharmaceuticals (TBET) Going Private Proposal At $3.00

The Company also announced its intent to accept a "going private" proposal by Mr. Hong Yu, and cease its public company status. "In view of market bias towards Chinese companies listed in U.S. stock exchange and our past stock performance, I hereby make an offer to purchase TBET stocks not owned by me for $3.00 per share in cash,"said Mr. Hong Yu, "delisting details will be announced shortly".

Press Release Yahoo Finance

At $1.81 there is still much to gain. So a real arbitrage opportunity!